Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
102 studies found for:    Open Studies | "Nervous System Malformations"
Show Display Options
Rank Status Study
21 Recruiting Genetic Analysis of the Chiari I Malformation
Conditions: Syringomyelia;   Type I Arnold Chiari Malformation
Intervention:
22 Recruiting A Prospective Natural History Study of Patients With Syringomyelia
Conditions: Syringomyelia;   Arnold Chiari Deformity
Intervention:
23 Not yet recruiting Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A
Condition: CMT1A
Interventions: Drug: EllaOne;   Drug: EllaOne placebo
24 Recruiting Influence of Pronator Teres Release on Treatment of Median Nerve Compression Neuropathy
Condition: Median Nerve Compression
Interventions: Procedure: Pronator Teres Release;   Procedure: dual compression release;   Procedure: median nerve release only
25 Recruiting Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)
Condition: Charcot-Marie-Tooth Disease
Intervention: Other: No intervention involved
26 Not yet recruiting Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy
Condition: Atunomic Neuropathy
Interventions: Other: kinesiology tape around the hip, knee and ankle joints;   Other: No kinesiology tape around the hip, knee and ankle joints
27 Not yet recruiting Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
Condition: Charcot-Marie-Tooth Disease Type 1A
Interventions: Other: Clinical evaluation;   Other: electrophysiological record;   Other: Muscle MRI;   Other: blood samples analysis
28 Recruiting Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Condition: Charcot-Marie-Tooth Disease Type 1A
Interventions: Drug: PXT3003 dose 1;   Drug: PXT3003 dose 2;   Drug: placebo
29 Recruiting Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Condition: Charcot Marie Tooth Disease
Intervention:
30 Recruiting Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
Conditions: Charcot-Marie-Tooth Disease, Type Ia (Disorder);   HMSN
Intervention:
31 Recruiting Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Condition: Charcot Marie Tooth Disease
Intervention:
32 Recruiting Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome
Conditions: Inflammation and Fibrosis;   Diabetes
Intervention: Drug: PBI-4050
33 Recruiting Carbidopa for the Treatment of Excessive Blood Pressure Variability
Conditions: Dysautonomia, Familial;   Baroreflex Failure Syndrome
Interventions: Drug: Carbidopa Low Dose;   Other: Placebo;   Drug: Carbidopa High Dose
34 Recruiting Suprascapular Neuropathy in the Setting of Rotator Cuff Tears: Results of Arthroscopic Treatment
Conditions: Entrapment Neuropathy;   Rotator Cuff Tear
Intervention: Procedure: Dissection of the superior transverse scapular ligament
35 Recruiting The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia
Condition: Familial Dysautonomia
Intervention: Dietary Supplement: Phosphatidylserine
36 Recruiting The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia
Condition: Familial Dysautonomia
Intervention: Dietary Supplement: Kinetin
37 Recruiting SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy;   Peripheral Neuropathy;   Charcot-Marie-Tooth Disease;   Charcot-Marie-Tooth Disease Type 1A;   Charcot-Marie-Tooth Disease, Type IA
Intervention: Drug: MD1003
38 Recruiting Clinical Study of a Single Ciliopathy: Alström Syndrome
Condition: Alström Syndrome (ALMS)
Intervention:
39 Not yet recruiting Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain
Conditions: Chronic Abdominal Wall Pain;   Abdominal Cutaneous Nerve Entrapment Syndrome
Interventions: Drug: Triamcinolone;   Other: Placebo;   Drug: Lidocaine
40 Recruiting Intrathecal Administration of scAAV9/JeT-GAN for the Treatment of Giant Axonal Neuropathy
Conditions: Giant Axonal Neuropathy;   Gene Transfer
Intervention: Drug: Intrathecal Delivery of scAAV9/JeT-GAN

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.